BRIAN ALLEE: Open Payments
NPI 1952340572 · PAULS VALLEY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 33 payments from 9 companies in 2025. Trend: 2023 $242 · 2024 $428 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $219 |
| Novo Nordisk Inc | 11 | $142 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Lilly USA, LLC | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $30 |
| Axsome Therapeutics, Inc. | 2 | $24 |
| Amgen Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: VRAYLAR, Ozempic, Rybelsus, MOUNJARO, UBRELVY, Saxenda, GEMTESA, Auvelity.
Industry payments across OK — which companies pay providers there.
